Cancer Outcomes Among Parkinson’s Disease Patients with Leucine Rich Repeat Kinase 2 Mutations, Idiopathic Parkinson’s Disease Patients, and Nonaffected Controls

BACKGROUND: Increased cancer risk has been reported in Parkinson’s disease (PD) patients carrying the leucine rich repeat kinase 2 (LRRK2) G2019S mutation (LRRK2-PD) in comparison with idiopathic PD (IPD). It is unclear whether the elevated risk would be maintained when compared with unaffected cont...

詳細記述

保存先:
書誌詳細
出版年:Mov Disord
主要な著者: Agalliu, llir, Ortega, Roberto A., San Luciano, Marta, Mirelman, Anat, Pont-Sunyer, Claustre, Brockmann, Kathrin, Vilas, Dolores, Tolosa, Eduardo, Berg, Daniela, Warø, Bjørg, Glickman, Amanda, Raymond, Deborah, Inzelberg, Rivka, Ruiz-Martinez, Javier, Mondragon, Elisabet, Friedman, Eitan, Hassin-Baer, Sharon, Alcalay, Roy N., Mejia-Santana, Helen, Aasly, Jan, Foroud, Tatiana, Marder, Karen, Giladi, Nir, Bressman, Susan, Saunders-Pullman, Rachel
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6754269/
https://ncbi.nlm.nih.gov/pubmed/31348549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27807
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料